Quince Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
37.00
|
|
Average Rating
|
2.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.31
|
0.00
|
0.31
|
100.00%
|
|
2022-12-31
|
-0.29
|
0.00
|
0.29
|
100.00%
|
|
2022-09-30
|
-0.28
|
-0.22
|
0.06
|
21.43%
|
|
2022-06-30
|
-0.48
|
-0.51
|
-0.03
|
-6.25%
|
|
2022-03-31
|
-0.55
|
-0.72
|
-0.17
|
-30.91%
|
|
2021-12-31
|
-0.65
|
-0.78
|
-0.13
|
-20.00%
|
|
2021-09-30
|
-0.74
|
-0.73
|
0.01
|
1.35%
|
|
2021-06-30
|
-0.76
|
-0.74
|
0.02
|
2.63%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.45
|
|
2021-12-31
|
-3.03
|
|
2020-12-31
|
-2.63
|
|
2019-12-31
|
-2.90
|